Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging

Neuroscience

Volumn 92, Issue 3, 1999, Pages 1035-1041

  Chyi, T ^a   Chang, C ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Excitotoxic; Neurodegenerative disease; Relative cerebral blood volume; Time course

Indexed keywords

3 NITROPROPIONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD VOLUME; BRAIN REGION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUNTINGTON CHOREA; MALE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; MAGNETIC RESONANCE IMAGING; MALE; NERVE DEGENERATION; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0033066072     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00076-7     Document Type: Article

References (60)

1. Albin L., Greenamyre J.T. Alternative excitotoxic hypotheses. Neurology. 42:1992;733-738.
2. Alston T.A., Mela L., Bright H.J. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. natn. Acad. Sci. U.S.A. 74:1977;3677-3771.
3. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
4. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192.
5. Berninger W.H., Axel L., Norman D., Napel S., Redington R.W. Functional imaging of the brain using computed tomography. Radiology. 138:1981;711-716.
6. Brouillet E., Jenkins B.G., Hyman B.T., Ferrante R.J., Kowall N.W., Srivastava R., Roy D.S., Rosen B.R., Beal M.F. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60:1993;356-359.
7. Brouillet E., Hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., Kowall N.W., Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. natn. Acad. Sci. U.S.A. 92:1995;7105-7109.
8. Brouillet E., Guyot M., Mittous V., Altairac S., Condé F., Palfi S., Hantraye P. Partial inhibition of brain succunate dehydogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70:1998;794-805.
9. Busija D.W., Heistad D.D. Factors involved in physiological regulation of cerebral blood flow. Rev. Physiol. Biochem. Pharmac. 101:1984;161-211.
10. Cadoux-Hudson T., Blamire A. M., Rowe J. G., Domingo Z., and Styles P. (1998) Sub-arachnoid haemorrhage induced delayed neurological deficits associated with lactate and increases blood flow volume. In Proceedings of the International Society for Magnetic Resonance in Medicine 6th Annual Meeting, Sydney, Australia, p. 1158.
11. 2-weighted, diffusion-weighted, and perfusion MRI. In Proceedings of the International Society for Magnetic Resonance in Medicine 6th Annual Meeting, Sydney, Australia, p. 1369.
12. Cordingley G.E., Weight F.F. Non-cholinergic synaptic excitation in neostriatum: pharmacological evidence for mediation by a glutamate-like transmitter. Br. J. Pharmac. 88:1986;847-856.
13. Ebisu T., Rooney W.D., Graham S.H., Mancuso A., Weiner M.W., Maudsley A.A. MR spectroscopic imaging and diffusion-weighted MRI for early detection of kainate-induced status epilepticus in the rat. Magn. Reson. Med. 36:1996;821-828.
14. 2*-weighted MR imaging at 1.5 T. Radiology. 176:1990;211-220.
15. Faraci F.M., Brain J.E. Nitric oxide and regulation of the cerebral circulation. Stroke. 25:1994;692-703.
16. Gerfen C.R. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature. 311:1984;461-464.
17. Halpain S., Weiczorek C.M., Rainbow T.C. Localization of L-glutamate receptors in rat brain by quantitative autoradiography. J. Neurosci. 4:1984;2247-2258.
18. Hamilton B.F., Gould D.H. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta neuropath., Berlin. 72:1987;286-297.
19. Hamilton B.F., Gould D.H. Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta neuropath., Berlin. 74:1987;67-74.
20. Jenkins B.G., Brouillet E., Chen Y.C., Storey E., Schulz J.B., Kirschner P., Beal M.F., Rosen B.R. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J. cerebr. Blood Flow Metab. 16:1996;450-461.
21. Kluytmans M., van der Ground J., Visser G. H., and Viergever M. A. (1998) Increased rCBV in patients with ICA occlusions: what does it mean? In Proceedings of the International Society for Magnetic Resonance in Medicine 6th Annual Meeting, Sydney, Australia, p. 1357.
22. Knowles R. J. and Markisz J. A. (1988) General imaging measurement. In Quality Assurance and Images Artifacts in Magnetic Resonance Image, p. 35. Brown Press, Boston.
23. La Noce A., Miragoli L., Samuelli G., Tirone P. An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia. Invest. Radiol. 31:1996;550-555.
24. Latour L., Svoboda K., Mitra P.P., Sotak C.H. Time-dependent diffusion of water in a biological model system. Proc. natn. Acad. Sci. U.S.A. 91:1994;1229-1233.
25. Laurent D., Eis M., Sauer D., Theilkaes W., Allergrini P.R. Reduction of excitotoxicity-induced brain damage by the competitive NMDA antagonist CGP 40116: a longitudinal study using diffusion-weighted imaging. Neurosci. Lett. 213:1996;209-212.
26. Levin J.M., Kaufman M.J., Ross M.H., Mendelson J.H., Maas L.C., Cohen B.M., Renshaw P.F. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn. Reson. Med. 34:1995;655-663.
27. Lutsep H.L., Albers G.W., De Crespigny A., Kamat G.N., Marks M.P., Moseley M.E. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann. Neurol. 41:1997;574-580.
28. Martin J.B., Gusella J.F. Huntington's disease. Pathogenesis and management. New Engl. J. Med. 315:1986;1267-1276.
29. Matthews R.T., Yang L., Jenkins B.G., Ferrante R.J., Rosen B.R., Kaddurah Daouk R., Beal M.F. Neuroprotective effects if creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18:1998;156-163.
30. McGeorge A.J., Faull R.L. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
31. 2-weighted MRI for the early detection of cerebral ischemia and perfusion in rats. Magn. Reson. Med. 18:1990;39-50.
32. 3H-L-glutamate binding sites. Nature. 306:1983;176-179.
33. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmac. Rev. 43:1991;109-142.
34. Moor E., Auth F., De Boer P., Westerink B.H. Septal and hippocampal glutamate receptors modulate the output of acetylcholine in hippocampus: a microdialysis study. J. Neurochem. 67:1996;310-316.
35. 2-weighted MRI and spectroscopy. Magn. Reson. Med. 14:1990;330-346.
36. 1H MRI and intravascular contrast agent study. Magn. Reson. Med. 23:1992;21-30.
37. Mottet I., Quast M.J., Dewitt D.S., Hillman G.R., Wei J., Uhrbrock D.H., Perez Polo J.R., Kent T.A. NG-nitro-L-arginine methyl ester modifies the input function measured by dynamic susceptibility contrast magnetic resonance imaging. J. cerebr. Blood Flow Metab. 17:1997;791-800.
38. Nighoghossian N., Berthezene Y., Meyer R., Cinotti L., Adeleine P., Philippon B., Froment J.C., Trouillas P. Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging. J. neurol. Sci. 149:1997;171-176.
39. Norris D.G., Niendorf T., Leibfritz D. Health and infarcted brain tissues studies at short diffusion times: the origins of apparent restriction and the reduction in apparent diffusion coefficient. NMR Biomed. 7:1994;304-310.
40. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
41. Palfi S., Ferrante R.J., Brouillet E., Beal M.F., Dolan R., Guyot M.C., Peschanski M., Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci. 16:1996;3019-3025.
42. Pan Y., Lo E.H., Matsumoto K., Hamberg L., Jiang H. Quantitative and dynamic MRI of neuroprotection in experimental stroke. J. neurol. Sci. 131:1995;128-134.
43. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, San Diego.
44. Porter J.T., Bright H.J. 3-Carbanionic substrate analogues bind very tightly to fumarase and aspartase. J. biol. Chem. 255:1980;4772-4780.
45. Riepe M., Hori N., Ludolph A.C., Carpenter D.O., Spencer P.S., Allen C.N. Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels. Brain Res. 586:1992;61-66.
46. Righini A., Pierpaoli C., Alger J.R., Di Chiro G. Brain parenchyma apparent diffusion coefficient alterations associated with experimental complex partial status epilepticus. Magn. Reson. Imaging. 12:1994;865-871.
47. Rosen B.R., Belliveau J.W., Vevea J.M., Brady T.J. Perfusion imaging with NMR contrast agent. Magn. Reson. Med. 14:1990;249-265.
48. Rosen B.R., Belliveau J.W., Aronen H.J., Kennedy D., Buchbinder B.R., Fischman A., Gruber M., Glas J., Weisskoff R.M., Cohen M.S., Hochberg F.H., Brady T.J. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn. Reson. Med. 22:1991;293-333.
49. Rosen B.R., Belliveau J.W., Buchbinder B.R., McKinstry R.C., Porkka L.M., Kennedy D.N., Neuder M.S., Fisel C.R., Aronen H.J., Kwong K.K., Weisskoff R.M., Cohen M.S., Brady T.J. Contrast agent and cerebral hemodynamics. Magn. Reson. Med. 19:1991;285-292.
50. Schulz J.S., Matthews R.T., Jenkins B.G., Ferrante R.J., Siwek D., Henshaw D.R., Cipolloni P.B., Mecocci P., Kowall N.W., Rosen B.R., Beal M.F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
51. Siegal T., Rubinstein R., Tzuk Shina T., Gomori J.M. Utility of relative cerebral blood flow mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J. Neurosurg. 86:1997;22-27.
52. Sobey C.G., Faraci F.M. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke. 28:1997;837-843.
53. Tokumitsu T., Mancuso A., Weinstein P.R., Weiner M.W., Naruse S., Maudsley A.A. Metabolic and pathological effects of temporal lobe epilepsy in rat brain detected by proton spectroscopy and imaging. Brain Res. 744:1997;57-67.
54. 1H nuclear magnetic resonance spectroscopy and biochemical characterization. Neuroscience. 79:1997;819-826.
55. van Lookeren Campagne M., Verheul J.B., Nicolay K., Balazs R. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology. J. cerebr. Blood Flow Metab. 14:1994;1011-1023.
56. 1H nuclear magnetic resonance imaging. Brain Res. 618:1993;203-212.
57. Villringer A., Rosen B.R., Belliveau J.W., Ackerman J.L., Lauffer R.B., Buxton R.B., Chao Y.S., Wedeen V.J., Brady T.J. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6:1988;164-174.
58. Wahl M., Schilling L. Regulation of cerebral blood flow - a brief review. Acta neurochir. 59(Suppl.):1993;3-10.
59. Warach S., Li W., Ronthal M., Edelman R.R. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology. 182:1992;41-47.
60. Warach S., Levin J.M., Schomer D., Holman B.L., Edelman R.R. Hyperperfusion of ictal seizure focus demonstrated by MR. Am. J. Neuroradiol. 15:1994;965-968.